AstraZeneca has announced plans to invest a multi-million sum into its £150m facility in Macclesfield, Chesire, UK – a move which the company said is “part of our ongoing investment in the UK”.
The Chesire facility currently employs 300 staff – image courtesy of AZ The £150m facility is used to produce the company’s breast cancer drugs, including Zoladex, which has seen its R&D efforts transferred to AZ’s laboratories at its Alderley Park site in Cambridge. The Chesire facility currently employs 300 staff and…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
